adamantane has been researched along with tosylphenylalanyl chloromethyl ketone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czajkowski, K; Lasek, W; Sieńko, J; Smolarczyk, R; Teliga-Czajkowska, J | 1 |
1 other study(ies) available for adamantane and tosylphenylalanyl chloromethyl ketone
Article | Year |
---|---|
Potentialization of N-a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) cytotoxic activity by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) in human ovarian cancer cells.
Topics: Adamantane; Aminopyridines; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Humans; Infliximab; Ovarian Neoplasms; Signal Transduction; Tosylphenylalanyl Chloromethyl Ketone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2017 |